Integra LifeSciences (NASDAQ:IART – Get Free Report) and PetVivo (NASDAQ:PETV – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, dividends, risk, profitability, valuation and earnings.
Insider and Institutional Ownership
84.8% of Integra LifeSciences shares are owned by institutional investors. Comparatively, 24.5% of PetVivo shares are owned by institutional investors. 3.1% of Integra LifeSciences shares are owned by insiders. Comparatively, 10.8% of PetVivo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Analyst Recommendations
This is a breakdown of current ratings and target prices for Integra LifeSciences and PetVivo, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Integra LifeSciences | 3 | 4 | 1 | 0 | 1.75 |
| PetVivo | 0 | 0 | 0 | 0 | 0.00 |
Risk and Volatility
Integra LifeSciences has a beta of 1.17, suggesting that its stock price is 17% more volatile than the S&P 500. Comparatively, PetVivo has a beta of 2.36, suggesting that its stock price is 136% more volatile than the S&P 500.
Earnings and Valuation
This table compares Integra LifeSciences and PetVivo”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Integra LifeSciences | $1.56 billion | 1.09 | $67.74 million | ($0.09) | -245.00 |
| PetVivo | $1.05 million | 11.23 | -$10.95 million | ($0.45) | -1.22 |
Integra LifeSciences has higher revenue and earnings than PetVivo. Integra LifeSciences is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Integra LifeSciences and PetVivo’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Integra LifeSciences | -0.42% | 12.35% | 4.82% |
| PetVivo | -902.82% | -4,813.07% | -281.78% |
Summary
Integra LifeSciences beats PetVivo on 10 of the 14 factors compared between the two stocks.
About Integra LifeSciences
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
About PetVivo
PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.
Receive News & Ratings for Integra LifeSciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integra LifeSciences and related companies with MarketBeat.com's FREE daily email newsletter.
